vium biotechnology, Vium

Vium | 924 followers on LinkedIn | Creating digital biomarkers to transform preclinical research and animal welfare. | Vium is the first company to create a living informatics platform for preclinical in vivo drug research. The Vium Digital Vivarium™, incorporating Vium Smart Housing™, Vium Cloud infrastructure, and online Research Suite software, empowers scientists to optimize advances

vium biotechnology, Vium

Vium | 927 obserwujących | Creating digital biomarkers to transform preclinical research and animal welfare. | Vium is the first company to create a living informatics platform for preclinical in vivo drug research. The Vium Digital Vivarium™, incorporating Vium Smart Housing™, Vium Cloud infrastructure, and online Research Suite software, empowers scientists to optimize advances in

Vium is a privately held biotechnology firm that was founded under the name Mousera in 2013. Vium has since rebranded and developed living informatics platforms, Digital Vivarium™ and Vium Cloud, both of which harness technology to enable biomedical investigators, scientists, and businesses working in preclinical drug discovery and development to administer high-quality research, expand data

Vium empowers biomedical investigators with technology that accelerates the preclinical drug discovery and development pipeline. Researchers can design, run, and analyze experiments that rapidly surface insights and high volumes of quality data.

Rydhaugen 9, Vium DK – 8620 Kjellerup Tel.: +45 8666 7488 [email protected] CVR: DK 84039810. Fakturaer sendes til: [email protected] Links. Contact; Company profile; Certificates; Development projects; Special machinery; Heavy Industry; Wind power; Designed by Elegant Themes |

CohBar, Inc. | 508 followers on LinkedIn | Harnessing the Therapeutic Potential of Mitochondrial DNA | CohBar (NASDAQ: CWBR) is a clinical stage biotechnology company focused on the research and development of mitochondria based therapeutics, an emerging class of drugs for the treatment of chronic and age-related diseases. Mitochondria based therapeutics originate from the discovery by CohBar

Vium empowers biomedical investigators with technology that accelerates the preclinical drug discovery and development pipeline. Researchers can design, run, and analyze experiments that rapidly surface insights and high volumes of quality data. The result is that better therapies get moved more quickly through to patients who need them.

The Vium Digital VivariumTM, Vium Cloud, and online Research Suite allow scientists to optimize advances in bioengineered research models. Customers run the spectrum of biotechnology,

Vium is fully accredited by AAALAC International and received an unprecedented AAALAC commendation for upholding the “3 Rs,” the gold-standard framework for humane animal research. Customers run the spectrum of biotechnology, pharmaceutical and computational drug discovery companies to academia and novel therapeutic labs. 50-100. Employees N/A.

vium biotechnology, Vium

Vium is fully accredited by AAALAC International and received an unprecedented AAALAC commendation for upholding the “3 Rs,” the gold-standard framework for humane animal research. Customers run the spectrum of biotechnology, pharmaceutical and computational drug discovery companies to academia and novel therapeutic labs.

Vium empowers biomedical investigators with technology that accelerates the preclinical drug discovery and development pipeline. Researchers can design, run, and analyze experiments that rapidly surface insights and high volumes of quality data.

Emil Stiil Vium er på Facebook. Bliv medlem af Facebook, og få kontakt med Emil Stiil Vium og andre, du måske kender. Facebook giver folk mulighed for at

Customers run the spectrum of biotechnology, pharmaceutical and computational drug discovery companies, academia, and novel therapeutic labs. Vium is backed by leading investors, including Lux Capital, Data Collective, Dolby Family Ventures, AME Cloud Ventures, Founders Fund, and Future Shape LLC. Vium is headquartered in San Mateo, California.

FibroGenesis. 101 likes. Based in Houston, Texas, FibroGenesis, is a regenerative medicine company developing an innovative regenerative medicine solution for chronic diseases using fibroblasts.

Vium, Inc., a San Mateo, Calif.–based company leveraging a living informatics approach to accelerate preclinical drug discovery and development, closed a $24m Series B financing. The round was

Data Collective’s investments range from San Mateo’s Vium, which is working on sensors that gather around-the-clock data from lab animals, and

Vium already enables five of the top 10 pharma companies as customers.” Today, leading global pharmaceutical and biotechnology companies rely upon Vium to enable previously unavailable longitudinal data such as non-interventional 24-hour diurnal breathing rate and motion metrics.